Curadev Pharma Pvt Ltd., of Uttar Pradesh, India, said it licensed lead small-molecule stimulator of interferon genes, or STING, agonist CRD-5500 and associated intellectual property to Takeda Pharmaceutical Co. Ltd., of Osaka, Japan. Financial terms were not disclosed.